PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 20262 citations

Selective Lipoprotein Removal Enables High-Purity EV Isolation from Plasma via Aptamer-Based Mesh Filtration.

View Full Paper
SJSangkuk JeonYKYJ KimUniversity of Wisconsin–MadisonSSSehyun Shin

Key Points

  • To develop a selective method for high-purity extracellular vesicle isolation from plasma by removing lipoprotein contaminants.
  • Developed ApoFilter, an aptamer-based mesh-filtration system
  • Used high-affinity aptamers to capture lipoproteins in a spin-column format
  • Conducted rapid, gravity-driven separation in under 1 minute
  • Integrated the system with conventional EV isolation techniques
  • Achieved over 99% depletion of ApoA1- and ApoB100-positive lipoproteins
  • Demonstrated minimal capture of non-target components
  • Maintained integrity of extracellular vesicles during purification
  • Consistently improved purity across different EV isolation methods

Abstract

Lipoproteins pose a major challenge to plasma extracellular vesicle (EV) isolation due to their abundance and physical similarity to EVs. Here, we present ApoFilter, a rapid and selective aptamer-based mesh-filtration platform that efficiently depletes ApoA1- and ApoB100-positive lipoproteins. High-affinity aptamers immobilized onto nylon mesh layers capture targeted lipoproteins in a spin-column format, enabling rapid (1 min) separation under gravity-driven flow. ApoFilter removed >99% of targeted lipoproteins (HDL and (V)LDL) from purified and plasma samples, with negligible capture of non-target components and no compromise to EV integrity. When integrated with conventional EV isolation methods-including ultracentrifugation (UC), size-exclusion chromatography (SEC), and ExoTFF-ApoFilter consistently eliminated lipoprotein contaminants across all workflows. This simple and rapid system addresses a key bottleneck in EV research, enabling the collection of ultrapure EVs suitable for downstream molecular analyses and translational applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jeon et al. (2026) studied this question.

synapsesocial.com/papers/69a91db5d6127c7a504c0c41https://doi.org/10.1002/smll.202514724
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improving immunological stability of EVs through lipoprotein depletion in plasma 91282025
  2. 2Improving the Purity of Extracellular Vesicles by Removal of Lipoproteins from Size Exclusion Chromatography- and Ultracentrifugation-Processed Samples Using Glycosaminoglycan-Functionalized Magnetic Beads2024 · 52 citations
  3. 3High-Efficiency Capture and Proteomic Analysis of Plasma-Derived Extracellular Vesicles through Affinity Purification2024
  4. 4Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications2026
  5. 5Solving the Contamination Conundrum Derived from Coisolation of Extracellular Vesicles and Lipoproteins: Approaches for Isolation and Characterization2025 · 8 citations